| Product Code: ETC8275287 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market - Industry Life Cycle |
3.4 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market - Porter's Five Forces |
3.5 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume Share, By ACE Inhibitors, 2021 & 2031F |
3.7 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic kidney disease (CKD) in Mexico |
4.2.2 Growing awareness about the importance of managing CKD-MBD |
4.2.3 Technological advancements in treatment options for CKD-MBD |
4.3 Market Restraints |
4.3.1 High treatment costs associated with managing CKD-MBD |
4.3.2 Limited access to specialized healthcare services in certain regions of Mexico |
5 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Trends |
6 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By Types |
6.1 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Medications And Supplements, 2021- 2031F |
6.1.4 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Dialysis, 2021- 2031F |
6.1.5 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Surgery, 2021- 2031F |
6.1.6 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Diet, 2021- 2031F |
6.1.7 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.1.8 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.2 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By ACE Inhibitors |
6.2.1 Overview and Analysis |
6.2.2 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By B-blockers, 2021- 2031F |
6.2.3 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Calcium Channel Blockers, 2021- 2031F |
6.2.4 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Loop Diuretics, 2021- 2031F |
6.2.5 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Erythropoiesis-Stimulating Agents (ESAs), 2021- 2031F |
6.2.6 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Phosphate Binders, 2021- 2031F |
6.2.7 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.3.4 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.3 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Ambulatory Surgical Centres, 2021- 2031F |
6.4.5 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.5.3 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.4 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.5 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.6 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Import-Export Trade Statistics |
7.1 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Export to Major Countries |
7.2 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Imports from Major Countries |
8 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Key Performance Indicators |
8.1 Number of patients undergoing treatment for CKD-MBD |
8.2 Adoption rate of new treatment modalities for CKD-MBD |
8.3 Rate of compliance with treatment guidelines for CKD-MBD |
8.4 Number of healthcare facilities offering specialized care for CKD-MBD |
8.5 Patient satisfaction levels with CKD-MBD treatment services |
9 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market - Opportunity Assessment |
9.1 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Opportunity Assessment, By ACE Inhibitors, 2021 & 2031F |
9.3 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market - Competitive Landscape |
10.1 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenue Share, By Companies, 2024 |
10.2 Mexico Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here